Visteon (VC) PT Raised to $145 at Jefferies

Jefferies analyst David Kelley raised the price target on Visteon (NASDAQ: VC) to $145.00 (from $132.00) while maintaining a Buy rating following results.

The analyst commented, "VC reported a 4Q sales & margin beat, while '22 guidance tracked above expectations. New product launches, content ramp, & customer mix should drive robust +18% '22 top-line growth. Margin recovery should benefit from underlying LVP ramp (note VC more bullish than peers) & recoveries. We remain upbeat on top-tier earnings expansion in '22, see a path to targeted $4bn in sales & 12%o EBITDA margin in '23. Raise ests., PT to $145."

You May Also Be Interested In

• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• B.Riley Assumes Anika Therapeutics (ANIK) at Buy
• BMO Capital Downgrades Magna Intl (MG:CN) (MGA) to Market Perform